^
Contact us to learn more about
our Premium Content: News alerts, weekly reports and conference plannersDRUG:
FT538
i
Other names: FT538, CRISPR-edited, iPSC-derived Cellular Immunotherapy, hnCD16/IL-15RF/CD38KO engineered iPSC-derived NK cell therapy
Contact us to learn more about our Premium Content:
News alerts, weekly reports and conference planners
Company:
Fate Therap, University of Minnesota
Drug class:
CD38 inhibitor, IL-15R stimulant, CD16 agonist
Related drugs:
